Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapse. 1978

F H Kung, and W L Nythan, and J Cuttner, and G Falkson, and P Lanzkowsky, and V Del Duca, and I U Nawabi, and K Koch, and H Pluess, and A Freeman, and E O Burgert, and L A Leone, and F Ruymann, and R B Patterson, and T Degnan, and N Hakami, and T F Pajak, and J Holland

Two hundred and twenty-seven children with recurrent acute lymphoblastic leukemia were treated with various combinations of vincristine, prednisone, cyclophosphamide and L-asparaginase in an approach to the induction of remission. The combination of L-asparaginase 1,000 mu/kg iv q.d. x 10, vincristine 2.0 mg/m2iv q.w. x 4 and prednisone 40 mg/m2 p.o.q.d. x 28 days was found to be highly effective. The incidence of remission was 73%. No significant improvement was achieved when cyclophosphamide was added to this regimen. Various combinations of cytosine arabinoside, cyclophosphamide, vincristine, prednisone, BCNU or CCNU failed to maintain remission duration for more than two or three months. Neither BCNU nor CCNU prevented the development of CNS leukemia.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008130 Lomustine An alkylating agent of value against both hematologic malignancies and solid tumors. CCNU,Belustine,Cecenu,CeeNU,NSC-79037,NSC 79037,NSC79037
D008297 Male Males
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002330 Carmustine A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed) BCNU,1,3-Bis(2-Chloroethyl)-1-Nitrosourea,BiCNU,FIVB,N,N'-Bis(2-Chloroethyl)-N-Nitrosourea,Nitrumon

Related Publications

F H Kung, and W L Nythan, and J Cuttner, and G Falkson, and P Lanzkowsky, and V Del Duca, and I U Nawabi, and K Koch, and H Pluess, and A Freeman, and E O Burgert, and L A Leone, and F Ruymann, and R B Patterson, and T Degnan, and N Hakami, and T F Pajak, and J Holland
January 1976, Medical and pediatric oncology,
F H Kung, and W L Nythan, and J Cuttner, and G Falkson, and P Lanzkowsky, and V Del Duca, and I U Nawabi, and K Koch, and H Pluess, and A Freeman, and E O Burgert, and L A Leone, and F Ruymann, and R B Patterson, and T Degnan, and N Hakami, and T F Pajak, and J Holland
January 1979, Medical and pediatric oncology,
F H Kung, and W L Nythan, and J Cuttner, and G Falkson, and P Lanzkowsky, and V Del Duca, and I U Nawabi, and K Koch, and H Pluess, and A Freeman, and E O Burgert, and L A Leone, and F Ruymann, and R B Patterson, and T Degnan, and N Hakami, and T F Pajak, and J Holland
May 1983, Cancer treatment reports,
F H Kung, and W L Nythan, and J Cuttner, and G Falkson, and P Lanzkowsky, and V Del Duca, and I U Nawabi, and K Koch, and H Pluess, and A Freeman, and E O Burgert, and L A Leone, and F Ruymann, and R B Patterson, and T Degnan, and N Hakami, and T F Pajak, and J Holland
February 1977, Cancer research,
F H Kung, and W L Nythan, and J Cuttner, and G Falkson, and P Lanzkowsky, and V Del Duca, and I U Nawabi, and K Koch, and H Pluess, and A Freeman, and E O Burgert, and L A Leone, and F Ruymann, and R B Patterson, and T Degnan, and N Hakami, and T F Pajak, and J Holland
June 1976, La Nouvelle presse medicale,
F H Kung, and W L Nythan, and J Cuttner, and G Falkson, and P Lanzkowsky, and V Del Duca, and I U Nawabi, and K Koch, and H Pluess, and A Freeman, and E O Burgert, and L A Leone, and F Ruymann, and R B Patterson, and T Degnan, and N Hakami, and T F Pajak, and J Holland
January 2014, Case reports in oncological medicine,
F H Kung, and W L Nythan, and J Cuttner, and G Falkson, and P Lanzkowsky, and V Del Duca, and I U Nawabi, and K Koch, and H Pluess, and A Freeman, and E O Burgert, and L A Leone, and F Ruymann, and R B Patterson, and T Degnan, and N Hakami, and T F Pajak, and J Holland
January 1977, Oncology,
F H Kung, and W L Nythan, and J Cuttner, and G Falkson, and P Lanzkowsky, and V Del Duca, and I U Nawabi, and K Koch, and H Pluess, and A Freeman, and E O Burgert, and L A Leone, and F Ruymann, and R B Patterson, and T Degnan, and N Hakami, and T F Pajak, and J Holland
April 2000, Cancer,
F H Kung, and W L Nythan, and J Cuttner, and G Falkson, and P Lanzkowsky, and V Del Duca, and I U Nawabi, and K Koch, and H Pluess, and A Freeman, and E O Burgert, and L A Leone, and F Ruymann, and R B Patterson, and T Degnan, and N Hakami, and T F Pajak, and J Holland
December 1969, British medical journal,
F H Kung, and W L Nythan, and J Cuttner, and G Falkson, and P Lanzkowsky, and V Del Duca, and I U Nawabi, and K Koch, and H Pluess, and A Freeman, and E O Burgert, and L A Leone, and F Ruymann, and R B Patterson, and T Degnan, and N Hakami, and T F Pajak, and J Holland
March 1976, Cancer,
Copied contents to your clipboard!